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bjectives This study sought to describe and compare a novel ﬂuoroscopic method and a
-dimensional transesophageal echocardiographic (TEE) method to localize mitral periprosthetic
eaks (PPLs) for transcatheter reduction.
ackground Transcatheter reduction of signiﬁcant regurgitation represents a modern and attractive
lternative to surgery for the treatment of mitral PPL in high-risk patients. Accurate localization and
recise communication between the echocardiographer and the interventional cardiologist are es-
ential for procedural success.
ethods We analyzed TEE and ﬂuoroscopic studies of patients with mitral PPL who underwent
ultiplane 2-dimensional TEE–guided transcatheter reduction in our institution. Periprosthetic leaks
ere routinely localized using the “surgeon’s-view” time-clock method during periprocedural TEE
ssessments. The 2-dimensional TEE examinations were later retrospectively reviewed by an echocar-
iographer blinded to procedural TEE ﬁndings. A corresponding surgeon’s-view time-clock method
as plotted for ﬂuoroscopic PPL localization. Using this ﬂuoroscopic method, ofﬂine ﬂuoroscopic
mages were reviewed by an independent interventional cardiologist blinded to TEE results. Agree-
ent between methods was evaluated.
esults Complete imaging data were available for analysis in 20 patients who, between 2002 and
009, underwent transcatheter reduction in which the defect was successfully crossed. There was
xcellent agreement between procedural TEE and retrospective TEE review for PPL localization
100%; p  0.0001) and between ﬂuoroscopic and procedural TEE localization (90%; 95% conﬁdence
nterval [CI]: 77% to 100%; p  0.0003). In the 2 cases where there was disagreement, ﬂuoroscopic
PL localization was adjacent to TEE localization.
onclusions The surgeon’s-view time-clock method of localizing PPL using 2-dimensional TEE is
ighly reproducible and allows ﬂuoroscopic localization using the same reference system with very
ood agreement. (J Am Coll Cardiol Intv 2011;4:107–14) © 2011 by the American College of
ardiology Foundation
rom the *Department of Medicine, Montreal Heart Institute/Université de Montréal, Montreal, Quebec, Canada; †Department
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108he incidence of significant periprosthetic leak (PPL) after
itral valve replacement has been shown to vary from 2.5%
o 22%, depending on patient population and regurgitation
everity (1–3). Although many of these leaks are small and
nsignificant, some are responsible for serious clinical com-
lications (4,5), which are difficult to treat medically.
ndeed, some patients with PPL exhibit sustained hemoly-
is, with severe anemia requiring repeated blood transfu-
ions (6). When the leak is large, it may be associated with
olume overload leading to refractory cardiac failure. Im-
roved imaging techniques with transesophageal echocardi-
graphy (TEE) have lead to increased detection of these
eaks (7,8). Surgical repair of PPL has traditionally been
he standard of care (9), and in recent years, percutaneous
eak reduction procedures have been reported with the
ff-label use of various types of occluder devices. These
ew transcatheter procedures provide an attractive alter-
ative for high surgical risk patients, with initial encour-
ging results (10 –16).
One of the main limitations encountered during these
ypes of interventional procedures remains the capacity to
precisely locate and cross the
leak-causing defect; hence, there
is an important role for both
fluoroscopic and TEE guidance.
To allow adequate localization
of PPL and successful transcath-
eter reduction, a common refer-
ence system for these 2 imaging
modalities is necessary for pre-
cise communication between the
echocardiographer and the in-
terventional cardiologist.
A method using multiplane 2-dimensional (2D) TEE
as been described to accurately localize mitral peripros-
hetic defects based on a ”surgeon’s-view” time-clock
ethod (SVTCM) (17,18). This method, used for pre-
perative assessment of PPL and guidance of surgical repair,
as shown excellent correlations with surgical findings.
hether a similar system could be used in conjunction with
uoroscopic evaluation for transcatheter reduction has never
een tested, to our knowledge. Hence, the objective of this
tudy is to describe and compare a novel fluoroscopic
VTCM with the 2D-TEE method to localize mitral PPLs
or transcatheter leak reduction.
ethods
tudy population. This study was approved by the Research
nd Ethics Committees of our institution. Complete TEE
nd fluoroscopic data were available for comparison in 20
atients who underwent transcatheter mitral PPL reduction
rocedures at the Montreal Heart Institute from June 2002
bbreviations and
cronyms
D  2-dimensional
D  3-dimensional
AA  left atrial appendage
PL  periprosthetic leak
VTCM  surgeon’s-view
ime-clock method
EE  transesophageal
chocardiographyo October 2009. All procedures were performed under peneral anesthesia. Fluoroscopic data were considered suit-
ble for analysis if a left anterior oblique with or without
audal view showed a guidewire, balloon, or device crossing
he paravalvular leak. In this study, TEE was performed by
xperienced echocardiographers, using GE Vivid 7 (GE
ealthcare, Milwaukee, Wisconsin) or Philips Sonos 5500
Philips Medical Systems, Andover, Massachusetts) imag-
ng systems, in all patients before and during procedures.
uring these TEE examinations, PPLs were prospectively
ocalized using the SVTCM. Images were stored in digital
ormat or on VHS videotapes.
All TEE images were reviewed by an independent
chocardiographer, blinded to clinical, echocardiographic,
nd fluoroscopic findings, in order to assess interobserver
eproducibility of PPL localization. If there was more than
leak, only the largest defect was reported for analysis
ecause it corresponds to the defect that was addressed for
ranscatheter reduction. Fluoroscopic images showing a
uidewire, a catheter, or a device crossing the PPL defect
ere reviewed by an interventional cardiologist, blinded to
EE and fluoroscopic findings, in order to assess the
uoroscopic localization of the PPL. Agreement with TEE
sing the fluoroscopic SVTCM was evaluated.
EE localization method. Localization of PPL using multi-
lane 2D-TEE can be reported in reference to neighboring
natomical landmarks, such as the atrial septum, the aortic
alve, or the left atrial appendage (LAA). The method used
n this study provides accurate anatomic localization, based
n the polar coordinate system of a surgeon’s-view time
lock (Fig. 1). By convention, the LAA was set at 9:00,
ecause this structure or its remnant can almost always be
dentified surgically when looking through the left atrium.
sing anatomic landmarks, the entire prosthetic ring could
e screened and PPL localized according to the TEE
egrees at which the leak is found, depending on whether
he defect is on the same side of the landmark or on the
pposite region. For example, at 0° (4-chamber view) using
he TEE anatomical view display (left atrium up), the
edial or left side of the screen, near the atrial septum,
orresponds to 0:00/12:00 on the surgeon’s view and the
ateral or right side on the screen corresponds to 6:00. At
0° (2-chamber view), the left side of the screen is at 3:00,
hereas the right side corresponds to 9:00, adjacent to the
AA. At 150° (3-chamber view), the aortic valve corre-
ponds to 11:00, whereas a defect occurring on the left side
f the display, opposite to the aortic valve, would correspond
o 5:00 (Figs. 1 and 2). Periprosthetic leak was reported as
single hour if the defect was very localized or, more
ommonly, a range of hours if the defect was larger.
luoroscopic localization method. The projection views to
erform the procedure were typically the right anterior
blique, and the left anterior oblique with or without caudal
ngulations, the latter being the most helpful to localize the
aravalvular leak. As no angiographic contrast was used
d
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109uring the procedures, fluoroscopic offline localization of
PL was possible only if a wire, a catheter, a sizing balloon,
r the occluder device was positioned across the leak. From
Figure 1. SVTCM to Localize PPL
Mitral mechanical prosthesis is shown. (A) Surgical view of the heart valves, fro
suture ring. (B) Transesophageal echocardiography degrees and corresponding
mechanical mitral and aortic prostheses and a tricuspid annuloplasty ring. Cor
maker electrode is in position. The surgeon’s-view time-clock method is shown
whereas 9:00 is on the left atrial appendage side. Ao  aortic; LAA  left atria
method; TR  tricuspid.
Figure 2. PPL Localization Method
Examples of a periprosthetic leak are shown with corresponding surgeon’s vie
diographic 2-, 3-, and 4-chamber views are shown as well as the correspondin
periprosthetic leaks are localized at 12:00 (A), 6:00 (B), 3:00 (C), 9:00 (D), 5:00
right ventricle; other abbreviations as in Figure 1.he available images for offline analysis, an independent
nterventional cardiologist, blinded to TEE results, visually
ssessed PPL localization based on sizing balloon or device
ove, the atria removed. The surgical time clock is drawn around the mitral
s on the surgeon’s-view time clock. (C) Left anterior oblique view showing
angiogram shows a patent right coronary artery. A right ventricular pace-
0 is in the upper position in the vertical axis and 3:00, on the septal side,
ndage; PPL  periprosthetic leak; SVTCM  surgeon’s-view time-clock
ocardiographic, and ﬂuoroscopic representations, respectively. The echocar-
ing planes in reference to the 12-h surgeon’s view. As described in Figure 1,
d 11:00 (F). LA  left atrium; LV  left ventricle; RA  right atrium; RV m ab
hour
onary
: 12:0
l appew, ech
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110osition, over a range of hours, using a fluoroscopic
VTCM (Figs. 1 and 2).
In the left anterior oblique view (at 30°) with or without
audal view, the mitral prosthetic ring is visualized en face as
mirror image of the surgeon’s view with 0:00/12:00 and
:00 in the vertical axis (12:00 at the upper position), and
:00 and 9:00 in the transverse axis with 3:00 on the left of
he display screen or septal side, and 9:00 on the right or
AA side. In general, most patients with valvular disease
ave landmarks such as aortic valve calcifications or a
rosthetic aortic valve, a tricuspid annuloplasty, or a pace-
aker wire, which give supplemental indices in localizing
PL. Figures 3 and 4 show examples of PPL localization by
EE and fluoroscopy in Patient #3 and Patient #20,
espectively.
tatistical analysis. Baseline data are presented as mean 
D, median (interquartile range), or number of patients
percentage). The TEE and fluoroscopic examinations were
Figure 3. TEE and Fluoroscopic PLL Localization
Example of a patient (#3) with periprosthetic leak reduction procedure. (A) Tra
device crossing the leak at 9:00 on the surgeon’s-view time clock with a small
prosthetic regurgitation. (B) Right anterior oblique 30° ﬂuoroscopic projection
electrode. A 10 mm  4 cm Ultra-Thin balloon (Boston Scientiﬁc, Natick, Mass
oblique view 40° caudal 15° projection showing waist of sizing balloon in a ra
echocardiography; other abbreviations as in Figure 1.ompared on a 1-h section-by-section basis (12 sections for
ach patient for each imaging modality) and on a patient-
y-patient basis. It was ruled that there was agreement
etween methods when there was overlap of 1 h or more for
PL localization on the SVTCM between the original
rospective TEE and the offline TEE review as well as
etween original prospective TEE and offline fluoroscopic
ocalizations. It was ruled that there was disagreement when
here was no overlap for PPL localization between methods.
or instance, if the TEE localization was 7:00 to 11:00 and
he fluoroscopic localization was 10:00 to 12:00, there was
greement (for patient-by-patient analysis) between meth-
ds because of an overlap of 1 h from 10:00 to 11:00
Patient #1). Proportion of agreement between echocardio-
raphic interpretations for the TEE method and proportion
f agreement between TEE and fluoroscopic examinations
ere provided with a 2-sided 95% confidence interval (CI),
hen applicable. The 2 proportions of agreement were also
phageal echocardiographic view showing a delivery catheter (arrow) with
al leak (arrowhead). The 2 smaller jets to the left represent functional intra-
ng mechanical prostheses in aortic and mitral position and a pacemaker
tts) is inﬂated to size the defect (arrow: balloon waist). (C) Left anterior
hours estimated between 8:00 and 10:00 (arrow). TEE  transesophagealnseso
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111ested against the null hypothesis of proportion of agree-
ent of 50% due to chance, using a binomial test statistic.
esults
he baseline characteristics of the 20 patients with complete
maging data who underwent transcatheter procedures be-
ween June 2002 and October 2009 and in whom the defect
as successfully crossed are listed in Table 1. All patients
xcept 1 (Patient #15) had mechanical mitral valve prosthe-
es: 16 bi-leaflet and 3 single tilting-disc valves (Patients #4,
18, and #20). In all patients, the defect approached for
Figure 4. TEE and Fluoroscopic PLL Localization
Example of a patient (#20) with successful periprosthetic leak reduction. (A) Tr
(AGA Medical) device (green arrow) released in position at 11:00 on the surge
(B) Left anterior oblique view 40° caudal 20° projection showing the releas
Figures 1 and 3.
Table 1. Baseline Characteristics (n  20)
Age, yrs 64.4 12.3
Men 10 (50%)
Atrial ﬁbrillation 19 (95%)
NYHA functional class III or IV pre-intervention 16 (80%)
Mean time since last MVR, months 87.8 67
Mean logistic EuroSCORE, % 15.4 9
Indication for transcatheter closure
Heart failure 12 (60%)
Severe hemolysis 1 (5%)
Both 7 (35%)
Ejection fraction, % 52.7 8.6
Ejection fraction 50% 2 (10%)
Mean interventional procedural time, min
Total 134.9 51
Fluoroscopy 54.8 27.6
Values are mean SD or n (%).
EuroSCORE  European System for Cardiac Operative Risk Evaluation; MVR  mitral valve
replacement (16 bi-leaflet valves, 3 single tilting-disc valves, and 1 bioprosthesis); NYHA NewpYork Heart Association.eduction was responsible for significant mitral regurgitation
grade 3 or 4). The indication for PPL closure was heart
ailure in 12 patients (60%), severe hemolysis in 1 patient
5%), and both in 7 patients (35%). Many of the 20 patients
ad multiple previous cardiac operations (median: 2, range
to 5). Most had significant comorbidities and high
eoperative risk, with a mean logistic EuroSCORE (Euro-
ean System for Cardiac Operative Risk Evaluation) of
5.4% (range 4% to 37%).
Localization of PPL reported according to the SVTCM
y prospective TEE, blinded TEE review, and fluoroscopy
re shown for the 20 patients included in Table 2. As
hown, some PPLs were very localized (single hour or 1-h
ange), whereas the majority were larger and spanned over a
ange of 2 to 4 h on the SVTCM representing one-sixth to
ne-third of the mitral annular circumference. All patients
ad grade 3 or 4 mitral regurgitation with a mean range of
ours of 2.67  1 h (prospective TEE assessment), 2.62 
.8 h (retrospective TEE assessment), and 1.8  0.4 h
fluoroscopic assessment). Because many PPLs spanned
ver more than 1 quadrant, a predominant quadrant was
ttributed. The distribution of PPL localizations by quad-
ant was as follows: predominantly septal (12:00 to 3:00) in
patients; posterior (3:00 to 6:00) in 4 patients; lateral
6:00 to 9:00) in 5 patients; and anterior (9:00 to 12:00)
n 6 patients.
Section-by-section comparisons were performed on a
otal of 240 single-hour sections (12 single-hour sections in
0 patients) for each localization method (i.e., prospective
EE, offline TEE review, and fluoroscopy; 240 sections 
) and showed that there was excellent agreement between
phageal echocardiographic views showing an Amplatzer Vascular Plug III
iew time clock with a very small residual leak on color Doppler (red arrow).
vice located between 10:00 and 11:00 (white arrow). Abbreviations as inanseso
on’s-v
ed derospective TEE and offline TEE review for PPL localiza-
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112ion (92.08%, 95% CI: 88.67% to 95.50%; p  0.0001,
hen compared with the null hypothesis of 50%), and there
as very good section-by-section agreement between pro-
pective TEE and fluoroscopic localization (80.00%, 95%
I: 74.94% to 85.06%; p  0.0001, when compared with
he null hypothesis of 50%).
Patient-by-patient analyses showed that there was excel-
ent agreement (overlap of 1 h) between prospective TEE
nd offline TEE review for PPL localization in all 20
atients (100%; p  0.0001, when compared with the null
ypothesis of 50%), and there was also excellent agreement
etween prospective TEE and fluoroscopic localization
90.00%, 95% CI: 76.85% to 100%; p  0.0003, when
ompared with the null hypothesis of 50%;). In 2 cases of
0, where there was disagreement (no overlap), TEE and
uoroscopic localizations were adjacent to one another (i.e.,
eparated only by a 1-h section).
The PPL reductions were attempted with the Amplatzer
uct Occluder, the Amplatzer mVSD Occluder, or more
ecently, with the Vascular Plug III (AGA Medical Corpo-
ation, Plymouth, Minnesota). Among the 20 procedures, 2
ere unsuccessful (Patients #3 and #11) for reasons unre-
ated to localization. In both, the catheter successfully
rossed the defect, but the implanted device caused pros-
Table 2. Comparison Between TEE and Fluoroscopic
Patient # TEE Localization 1
TEE Localization 1
Predominant Quadran
1 7:00–11:00 Anterior
2 7:00–10:00 Lateral
3 7:00–9:00 Lateral
4 2:00 Septal
5 1:00–4:30 Septal
6 2:00–5:00 Posterior
7 6:00–9:00 Lateral
8 9:00–10:00 Anterior
9 8:00–11:00 Anterior
10 12:00–2:00 Septal
11 2:00–5:00 Posterior
12 7:00 Lateral
13 1:00–5:00 Septal
14 2:00–4:00 Posterior
15 2:00–6:00 Posterior
16 8:00–12:00 Anterior
17 1:00–3:00 Septal
18 6:00–9:00 Lateral
19 8:00–10:00 Anterior
20 9:00–12:00 Anterior
Transesophageal echocardiography (TEE) localization 1 represents th
procedure. TEE localization 2 and fluoroscopic localization represent
Agreement: overlap of 1 h between fluoroscopic localization and T
localization and TEE localization 1 methods. *Patient-by-patient comp
PPL periprosthetic leak.hetic disk mobility interference and was immediately re- Moved. In Patient #18, an mVSD Occluder was successfully
eplaced by a Vascular Plug III because the mono-disk
obility of the Medtronic Hall valve was impaired by the
rst device, whereas for Patient #20, a Vascular Plug III was
onsidered unstable and was replaced by an mVSD Oc-
luder. No other procedural complications occurred.
iscussion
his study demonstrates excellent reproducibility of the
VTCM to localize mitral PPL by 2D-TEE and very good
greement with the described novel fluoroscopic method.
his multimodality method represents a highly valuable tool
or the guidance of transcatheter PPL reduction, which we
ave been performing in our center since 2002 (14). We
eveloped this common reference system to precisely local-
ze the defect by TEE and fluoroscopy with the goal to
mprove communication between echocardiographer and
nterventional cardiologist. We now routinely use this
VTCM, allowing effective and simple communication
etween caregivers.
The method used in our study is very reproducible and
asy to use with a systematic and comprehensive approach,
nd it provides a detailed and complete evaluation of PPL.
ocalizations (n  20)
EE Localization 2
Fluoroscopic
Localization
Patient-by-Patient
Comparison*
8:00–11:00 10:00–12:00 Agreement
7:30–10:00 10:00–11:00 Agreement
6:00–10:00 8:00–10:00 Agreement
2:00–3:00 2:00–4:00 Agreement
1:00–4:30 3:00–5:00 Agreement
2:00–5:00 6:00–7:00 Disagreement
6:00–9:00 7:00–9:00 Agreement
9:00–10:00 10:00–12:00 Agreement
8:00–11:00 9:00–11:00 Agreement
12:00–2:00 1:00–3:00 Agreement
2:00–5:00 3:00–5:00 Agreement
7:00 8:00–10:00 Disagreement
1:00–5:00 3:00–4:00 Agreement
3:00–5:00 4:00–6:00 Agreement
3:00–6:00 3:00–5:00 Agreement
7:00–10:00 9:00–11:00 Agreement
0:00–3:00 2:00–4:00 Agreement
3:00–6:00 6:00–8:00 Agreement
7:00–10:00 10:00–12:00 Agreement
9:00–11:00 10:00–11:00 Agreement
al interpretation by the echocardiographer before the interventional
tation during blinded review, and as such, are retrospective reviews.
lization 1 methods. Disagreement: no overlap between fluoroscopic
s between fluoroscopic localization and TEE localization 1.PPL L
t T
e origin
interpre
EE loca
arison ioreover, this reference system is more accurate than the
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113uadrant method (19), especially when the leak overlaps
ore than a single quadrant. This method has the advan-
age of representing a standardized nomenclature to localize
PL and has the potential, not only in our center, but also
n others, to improve communication between echocardio-
raphers, interventional cardiologists, and cardiac surgeons,
ecause it is a common reference system based on the
natomical representation of the mitral annulus. This is
mportant because patients with PPL represent a “difficult-
o-treat” population, and transcatheter PPL reduction is a
echnically demanding procedure with a steep learning
urve.
During the procedure, both imaging modalities are es-
ential. Fluoroscopy is important during insertion of guide-
ires, catheter delivery, and device deployment. Ultrasound
s used to localize and assess the defect, guide transseptal
uncture and guidewire introduction, and ensure correct
evice delivery. Transesophageal echocardiography is also
xtremely useful, not only for localization and procedural
uidance, but also to rule out immediate complications such
s prosthetic dysfunction associated with the device or
ericardial hemorrhage, and TEE gives immediate feedback
n the results of the procedure by visualizing and grading
everity of residual regurgitation. Moreover, TEE guidance
voids the use of potentially nephrotoxic contrast agents in
hese fragile patients. Initial reported experiences of trans-
atheter PPL closure under TEE guidance have shown
romising results (10–16,20).
Recently, a new generation of TEE probes with a novel
atrix array was introduced, allowing 3-dimensional (3D)
epresentation of cardiac structures in real time with high
patial resolution. Three-dimensional TEE has been used to
uide various transcatheter procedures such as atrial or
entricular septal defect closures, valvular procedures, and
lectrophysiological interventions (21), and very recently,
as been described for transcatheter reduction of PPL
22–24). This technique has the potential to increase the
ase of localization and, potentially, the efficacy of PPL
eductions. However, precise anatomical knowledge re-
ains essential for the interventional cardiologists who
erform these procedures and for the echocardiographers
nvolved in PPL evaluation and procedural guidance. The
PL localization should be reported in a standardized
ashion, regardless of the imaging technique used, to ensure
roper communication between caregivers. The SVTCM
an readily be applied to 3D echocardiography, and appli-
ation of this methodology has the potential to simplify 3D
nterpretation and reporting. Placing the mitral prosthesis in
D anatomical or surgeon’s view should allow direct and
imple interpretation for localization of PPL that could be
eported using a single standardized method for echocar-
iographers, surgeons, and interventional cardiologists, as
escribed in this study.tudy limitations. This is a retrospective analysis of echo-
ardiographic and fluoroscopic data. To allow comparison
f fluoroscopic PPL localization with TEE, only patients in
hom the defect was actually crossed with a catheter or
evice could be included. The number of patients is limited,
ut percutaneous reduction procedures are reserved for
igh-risk patients after intensive multidisciplinary evalua-
ion, and to date, reported series include small numbers of
atients (10–16). To limit bias, an echocardiographer
linded to previous findings independently reviewed the
chocardiographic data offline, and an interventional cardi-
logist who was not the principle operator, also blinded to
revious findings, reviewed the fluoroscopic data offline.
omparison of the fluoroscopic method was made with the
riginal, prospectively acquired TEE images and interpre-
ations. The localizations of PPL were, by chance, evenly
istributed among all 4 quadrants in our study population.
onclusions
ocalization of PPL with the novel fluoroscopic SVTCM
hows very good agreement with the highly reproducible
EE method. In our experience, the use of this method
rovides a standardized nomenclature for echocardio-
raphers and interventional cardiologists, and it improves
ommunication and image guidance for these complex
nterventions, allowing better care for patients with PPL.
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